Deep techs can now register for a notice that will invest up to R$100,000 in solutions in the area of ​​oncology

Business Technology

Registration is open for a challenge that encourages the development of technological solutions aimed at the area of ​​oncology, which are applicable to the Unified Health System (SUS). The Inova SUS Notice provides for financial support of up to R$100,000 in deep techs, which can register on the Sebrae Startups platform.

The notice is part of the Technological Challenge for the Unified Health System – SUS Hackathon and was launched by Sebrae and the Ministry of Health on the 17th, during the opening of the SUS Inova Brasil Fair, in Rio de Janeiro (RJ). The initiative is the result of the Technical Cooperation Agreement (ACT) signed between Sebrae, the ministries of Health and Development, Industry and Commerce (MDIC), the National Health Surveillance Agency (Anvisa), the Brazilian Hospital Services Company (HU Brasil), which coordinates the network of University Hospitals, and the Pan American Health Organization (OPAS).

The objective is to support technology-based companies in health and university hospitals through training actions, qualification in health regulation and incentives for innovation. During the launch of the notice, Sebrae’s technical director, Bruno Quick, highlighted the importance of innovation for the country’s public health. “Today, we see other countries pushing innovation through the defense system, but in Brazil it is different. It is very beautiful to see our health system pushing innovation in our country”, he commented.

About the notice

Scheduled to run until April 2027, the notice will select, accelerate and reward Brazilian startups in the health sector capable of developing medical devices and technological solutions that face real challenges in oncology, with potential for social impact, scalability and economic sustainability.

Sebrae will support 15 selected startups, three per region of the country, through acceleration actions for six months. Participating startups will face two challenges. The first will be to create a medical device for diagnosis and clinical monitoring in oncology. The second is to develop instruments and devices (active or non-active) to expand oncological surgical capacity.

At the end of the process, the best solutions will be awarded with resources from the Ministry of Health, with R$ 100 thousand for first place; R$50 thousand for the second and R$30 thousand for the third. In addition to financial recognition, participating startups will have access to mentoring, training and experimentation environments, increasing the chances of validating and incorporating the solutions developed into the SUS.

The partnership also provides for the training of small innovative companies in regulatory aspects, both in relation to Anvisa’s requirements and the requirements necessary for incorporating technologies into the SUS.

Source: www.agenciasebrae.com.br
Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

four × three =